vs
CAPRICOR THERAPEUTICS, INC.（CAPR）与TRANSACT TECHNOLOGIES INC（TACT）财务数据对比。点击上方公司名可切换其他公司
TRANSACT TECHNOLOGIES INC的季度营收约是CAPRICOR THERAPEUTICS, INC.的1.0倍（$11.5M vs $11.1M），TRANSACT TECHNOLOGIES INC同比增速更快（11.9% vs -7.9%），TRANSACT TECHNOLOGIES INC自由现金流更多（$589.0K vs $-15.3M），过去两年CAPRICOR THERAPEUTICS, INC.的营收复合增速更高（93.0% vs 3.5%）
Capricor Therapeutics是一家处于临床阶段的生物技术企业，专注于研发及商业化细胞疗法、基因疗法等创新生物制剂，覆盖罕见病、心血管疾病、肌肉疾病等领域，主要面向美国市场，致力为治疗选择有限的患者填补未被满足的医疗需求。
该公司相关归属主体罗珀技术公司是一家控股集团，主要投资控股科技领域的各类企业，业务覆盖多个科技细分赛道，依托旗下子公司开展多元化科技业务布局。
CAPR vs TACT — 直观对比
营收规模更大
TACT
是对方的1.0倍
$11.1M
营收增速更快
TACT
高出19.9%
-7.9%
自由现金流更多
TACT
多$15.9M
$-15.3M
两年增速更快
CAPR
近两年复合增速
3.5%
损益表 — Q4 FY2024 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $11.1M | $11.5M |
| 净利润 | $-7.1M | — |
| 毛利率 | — | 47.6% |
| 营业利润率 | -69.1% | -10.1% |
| 净利率 | -63.9% | — |
| 营收同比 | -7.9% | 11.9% |
| 净利润同比 | -833.8% | — |
| 每股收益（稀释后） | $-0.11 | $-0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CAPRTACT
| Q4 25 | — | $11.5M | ||
| Q3 25 | — | $13.2M | ||
| Q2 25 | — | $13.8M | ||
| Q1 25 | — | $13.1M | ||
| Q4 24 | $11.1M | $10.2M | ||
| Q3 24 | $2.3M | $10.9M | ||
| Q2 24 | $4.0M | $11.6M | ||
| Q1 24 | $4.9M | $10.7M |
净利润CAPRTACT
| Q4 25 | — | — | ||
| Q3 25 | — | $15.0K | ||
| Q2 25 | — | $-143.0K | ||
| Q1 25 | — | $19.0K | ||
| Q4 24 | $-7.1M | — | ||
| Q3 24 | $-12.6M | $-551.0K | ||
| Q2 24 | $-11.0M | $-319.0K | ||
| Q1 24 | $-9.8M | $-1.0M |
毛利率CAPRTACT
| Q4 25 | — | 47.6% | ||
| Q3 25 | — | 49.8% | ||
| Q2 25 | — | 48.2% | ||
| Q1 25 | — | 48.7% | ||
| Q4 24 | — | 44.2% | ||
| Q3 24 | — | 48.1% | ||
| Q2 24 | — | 52.7% | ||
| Q1 24 | — | 52.6% |
营业利润率CAPRTACT
| Q4 25 | — | -10.1% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | -1.9% | ||
| Q1 25 | — | -0.1% | ||
| Q4 24 | -69.1% | -10.3% | ||
| Q3 24 | -575.2% | -7.7% | ||
| Q2 24 | -291.9% | -3.8% | ||
| Q1 24 | -209.2% | -12.2% |
净利率CAPRTACT
| Q4 25 | — | — | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | -1.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | -63.9% | — | ||
| Q3 24 | -555.2% | -5.1% | ||
| Q2 24 | -277.0% | -2.8% | ||
| Q1 24 | -199.6% | -9.7% |
每股收益（稀释后）CAPRTACT
| Q4 25 | — | $-0.11 | ||
| Q3 25 | — | $0.00 | ||
| Q2 25 | — | $-0.01 | ||
| Q1 25 | — | $0.00 | ||
| Q4 24 | $-0.11 | $-0.80 | ||
| Q3 24 | $-0.38 | $-0.06 | ||
| Q2 24 | $-0.35 | $-0.03 | ||
| Q1 24 | $-0.31 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $151.5M | $20.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $145.5M | $31.1M |
| 总资产 | $170.5M | $44.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CAPRTACT
| Q4 25 | — | $20.4M | ||
| Q3 25 | — | $20.0M | ||
| Q2 25 | — | $17.7M | ||
| Q1 25 | — | $14.2M | ||
| Q4 24 | $151.5M | $14.4M | ||
| Q3 24 | $85.0M | $11.3M | ||
| Q2 24 | $29.5M | $11.1M | ||
| Q1 24 | $39.9M | $10.6M |
股东权益CAPRTACT
| Q4 25 | — | $31.1M | ||
| Q3 25 | — | $31.8M | ||
| Q2 25 | — | $31.3M | ||
| Q1 25 | — | $30.9M | ||
| Q4 24 | $145.5M | $30.6M | ||
| Q3 24 | $68.3M | $38.4M | ||
| Q2 24 | $11.5M | $38.5M | ||
| Q1 24 | $18.4M | $38.6M |
总资产CAPRTACT
| Q4 25 | — | $44.8M | ||
| Q3 25 | — | $45.0M | ||
| Q2 25 | — | $44.5M | ||
| Q1 25 | — | $44.2M | ||
| Q4 24 | $170.5M | $44.0M | ||
| Q3 24 | $93.0M | $50.5M | ||
| Q2 24 | $38.3M | $50.4M | ||
| Q1 24 | $49.4M | $51.9M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.8M | $609.0K |
| 自由现金流经营现金流 - 资本支出 | $-15.3M | $589.0K |
| 自由现金流率自由现金流/营收 | -137.3% | 5.1% |
| 资本支出强度资本支出/营收 | 4.4% | 0.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-41.2M | $7.6M |
8季度趋势，按日历期对齐
经营现金流CAPRTACT
| Q4 25 | — | $609.0K | ||
| Q3 25 | — | $3.6M | ||
| Q2 25 | — | $3.6M | ||
| Q1 25 | — | $-161.0K | ||
| Q4 24 | $-14.8M | $2.4M | ||
| Q3 24 | $-11.6M | $327.0K | ||
| Q2 24 | $-12.3M | $636.0K | ||
| Q1 24 | $-1.3M | $-1.5M |
自由现金流CAPRTACT
| Q4 25 | — | $589.0K | ||
| Q3 25 | — | $3.6M | ||
| Q2 25 | — | $3.6M | ||
| Q1 25 | — | $-171.0K | ||
| Q4 24 | $-15.3M | $2.4M | ||
| Q3 24 | $-11.7M | $259.0K | ||
| Q2 24 | $-12.3M | $499.0K | ||
| Q1 24 | $-1.9M | $-1.6M |
自由现金流率CAPRTACT
| Q4 25 | — | 5.1% | ||
| Q3 25 | — | 27.1% | ||
| Q2 25 | — | 25.9% | ||
| Q1 25 | — | -1.3% | ||
| Q4 24 | -137.3% | 23.2% | ||
| Q3 24 | -515.2% | 2.4% | ||
| Q2 24 | -310.9% | 4.3% | ||
| Q1 24 | -38.3% | -14.9% |
资本支出强度CAPRTACT
| Q4 25 | — | 0.2% | ||
| Q3 25 | — | 0.5% | ||
| Q2 25 | — | 0.1% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | 4.4% | 0.1% | ||
| Q3 24 | 0.4% | 0.6% | ||
| Q2 24 | 1.5% | 1.2% | ||
| Q1 24 | 12.4% | 1.0% |
现金转化率CAPRTACT
| Q4 25 | — | — | ||
| Q3 25 | — | 242.00× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -8.47× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
